BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 26294706)

  • 1. Longitudinal Course of Clients With Co-occurring Schizophrenia-Spectrum and Substance Use Disorders in Urban Mental Health Centers: A 7-Year Prospective Study.
    Drake RE; Luciano AE; Mueser KT; Covell NH; Essock SM; Xie H; McHugo GJ
    Schizophr Bull; 2016 Jan; 42(1):202-11. PubMed ID: 26294706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 10-year study of steady employment and non-vocational outcomes among people with serious mental illness and co-occurring substance use disorders.
    McHugo GJ; Drake RE; Xie H; Bond GR
    Schizophr Res; 2012 Jul; 138(2-3):233-9. PubMed ID: 22546432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study.
    McHugo GJ; Drake RE; Teague GB; Xie H
    Psychiatr Serv; 1999 Jun; 50(6):818-24. PubMed ID: 10375153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders.
    Xie H; McHugo GJ; Helmstetter BS; Drake RE
    Schizophr Res; 2005 Jun; 75(2-3):337-48. PubMed ID: 15885525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders.
    Drake RE; McHugo GJ; Xie H; Fox M; Packard J; Helmstetter B
    Schizophr Bull; 2006 Jul; 32(3):464-73. PubMed ID: 16525088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.
    Compton MT; Weiss PS; West JC; Kaslow NJ
    Soc Psychiatry Psychiatr Epidemiol; 2005 Dec; 40(12):939-46. PubMed ID: 16247563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year outcomes of long-term patients with co-occurring bipolar and substance use disorders.
    Drake RE; Xie H; McHugo GJ; Shumway M
    Biol Psychiatry; 2004 Nov; 56(10):749-56. PubMed ID: 15556119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rural and urban differences in patients with a dual diagnosis.
    Mueser KT; Essock SM; Drake RE; Wolfe RS; Frisman L
    Schizophr Res; 2001 Mar; 48(1):93-107. PubMed ID: 11278157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance abuse and first-episode schizophrenia-spectrum disorders. The Danish OPUS trial.
    Petersen L; Jeppesen P; Thorup A; Ohlenschlaeger J; Krarup G; Ostergård T; Jørgensen P; Nordentoft M
    Early Interv Psychiatry; 2007 Feb; 1(1):88-96. PubMed ID: 21352112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and service utilization patterns of clients with schizophrenia-spectrum disorders in public residential detoxification settings.
    Alvidrez J; Havassy BE
    Community Ment Health J; 2006 Apr; 42(2):131-42. PubMed ID: 16425102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use.
    Margolese HC; Carlos Negrete J; Tempier R; Gill K
    Schizophr Res; 2006 Mar; 83(1):65-75. PubMed ID: 16460917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
    Jerrell JM; Ridgely MS
    Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Needs of Aboriginal Australian women with comorbid mental and alcohol and other drug use disorders.
    Lee KS; Harrison K; Mills K; Conigrave KM
    Drug Alcohol Rev; 2014 Sep; 33(5):473-81. PubMed ID: 24666748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol and substance use by patients with psychosis presenting to an emergency department: changing patterns.
    Latt N; Jurd S; Tennant C; Lewis J; Macken L; Joseph A; Grochulski A; Long L
    Australas Psychiatry; 2011 Aug; 19(4):354-9. PubMed ID: 21851228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance abuse, community service use, and symptom severity of urban and rural residents with schizoprhenia.
    Fischer EP; Owen RR; Cuffel BJ
    Psychiatr Serv; 1996 Sep; 47(9):980-4. PubMed ID: 8875665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian functioning and quality of life in substance use disorder patients with and without comorbid schizophrenia.
    Hashemzadeh I; Navarro JF; Adan A
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jan; 120():110623. PubMed ID: 36029929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A qualitative study of career exploration among young adult men with psychosis and co-occurring substance use disorder.
    Luciano A; Carpenter-Song EA
    J Dual Diagn; 2014; 10(4):220-5. PubMed ID: 25391280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of substance use disorder treatment outcomes among patients with psychotic disorders.
    Boden MT; Moos R
    Schizophr Res; 2013 May; 146(1-3):28-33. PubMed ID: 23453585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.